ZFAND6

ZFAND6 (AWP1) is a cytoplasmic ubiquitin-binding adaptor that uses its tandem A20 and AN1 zinc-finger domains to couple ubiquitinated cargo to AAA-ATPase- and TRAF-dependent machinery across peroxisomal protein import, TNF-α/NF-κB signaling, and mitochondrial quality control (PMID:21980954, PMID:21810480, PMID:39811672). In peroxisomal receptor recycling, it acts as a cofactor of the Pex6 AAA ATPase: its A20 domain preferentially binds cysteine-monoubiquitinated Pex5, and recombinant ZFAND6 stimulates Pex5 export while its depletion impairs PTS1-protein import and destabilizes Pex5 (PMID:21980954). In TNF-α signaling, ZFAND6 binds the C-terminal TRAF domain of TRAF2 through its AN1 domain and negatively regulates NF-κB activation through its A20 domain, which promotes K48-linked ubiquitination of TRAF2; loss of ZFAND6 augments NF-κB activity through a Nox1/ROS-dependent route and drives migration and EMT gene expression (PMID:21810480, PMID:33816268). In mitochondrial homeostasis, ZFAND6 bridges a TRAF2–cIAP1 interaction and recruits TRAF2 to damaged mitochondria to initiate ubiquitin-dependent mitophagy, so that its deletion in macrophages causes accumulation of damaged mitochondria, ROS, cytoplasmic mitochondrial DNA, and spontaneous cGAS-STING-driven interferon-stimulated gene expression (PMID:39811672). Studies of metazoan orthologs extend this adaptor role to developmental signaling, where ZFAND6 supports Wnt/β-catenin-dependent neural crest induction in Xenopus and JAK/STAT receptor trafficking in Drosophila (PMID:24623074, PMID:36861793).

1. 2000 Medium

   Established ZFAND6/AWP1 as a real protein with a defined domain architecture and a first physical partner, framing it as a kinase-associated factor.

   Evidence Co-immunoprecipitation of mouse AWP1 with rat PRK1 in COS-1 cells plus sequence-based A20/AN1 domain annotation

   PMID:11054541

   Open questions at the time

   • Functional consequence of the PRK1 interaction not defined
   • Single reciprocal Co-IP without orthogonal validation
   • No link between PRK1 binding and later-described pathways
2. 2005 Low

   Placed the protein in the cytoplasm, consistent with an adaptor that acts on cytosolic and membrane-associated machinery rather than in the nucleus.

   Evidence GFP-AWP1 live fluorescence microscopy in transfected 293 cells

   PMID:15698998

   Open questions at the time

   • Overexpression artifact possible
   • No endogenous localization
   • No functional readout tied to localization
3. 2011 High

   Defined a concrete biochemical function: ZFAND6 reads cysteine-monoubiquitinated Pex5 through its A20 domain and acts as a Pex6 cofactor in peroxisomal receptor export.

   Evidence In vitro reconstituted Pex5 export assay with recombinant protein, antibody inhibition, domain-deletion binding, and RNAi with import readout

   PMID:21980954

   Open questions at the time

   • How A20 ubiquitin recognition couples to Pex6 ATPase cycle mechanistically unresolved
   • Whether peroxisomal and TNF/TRAF roles compete for the same protein pool unknown
4. 2011 High

   Resolved a separate signaling function and assigned domain division of labor: AN1 mediates TRAF2 binding while A20 drives K48-ubiquitination of TRAF2 to dampen NF-κB.

   Evidence Yeast two-hybrid, domain-deletion binding, shRNA knockdown with NF-κB reporter and apoptosis assays, and overexpression ubiquitination assays

   PMID:21810480

   Open questions at the time

   • Whether ZFAND6 itself ligates ubiquitin or recruits an E3 not determined
   • Stoichiometry and kinetics of TRAF2 turnover not measured
5. 2013 Medium

   Extended the adaptor role to developmental signaling, showing the ortholog acts upstream of β-catenin stability in Wnt-dependent neural crest induction.

   Evidence Morpholino knockdown in Xenopus with constitutively active β-catenin/TCF3 rescue and Wnt luciferase reporter

   PMID:24623074

   Open questions at the time

   • Molecular target linking ZFAND6 to β-catenin stability unidentified
   • Conservation of this Wnt role in mammals untested
6. 2021 Medium

   Defined the mechanism of NF-κB suppression in a cancer context, linking ZFAND6 loss to Nox1/ROS-driven NF-κB activation and EMT.

   Evidence CRISPR/Cas9 knockout and shRNA in MCF-7 cells with ROS measurement and NF-κB inhibitor/ROS-scavenger rescue

   PMID:33816268

   Open questions at the time

   • Mechanistic link between TRAF2 regulation and Nox1 induction unresolved
   • Single cell-line context
7. 2023 Medium

   Clarified the ortholog's role in receptor trafficking, showing it promotes endocytic degradation of the JAK/STAT receptor Domeless to enable signaling.

   Evidence Drosophila loss-of-function genetics, Drn/Dome co-localization imaging, and analysis of receptor accumulation in ubiquitylated cargo compartments

   PMID:36861793

   Open questions at the time

   • Direct ubiquitin-cargo binding by Drn not demonstrated biochemically
   • Relevance to mammalian receptor trafficking unestablished
8. 2024 High

   Integrated ZFAND6 into mitochondrial quality control, showing it bridges TRAF2-cIAP1 and recruits TRAF2 to damaged mitochondria to drive mitophagy and restrain cGAS-STING immunity.

   Evidence ZFAND6 deletion in bone marrow-derived macrophages with mitophagy and ROS assays, TRAF2-cIAP1 Co-IP, mitochondrial recruitment imaging, and cGAS-STING readout

   PMID:39811672

   Open questions at the time

   • Whether ZFAND6 A20/AN1 ubiquitin chemistry is required for mitochondrial recruitment not dissected
   • Identity of the mitochondrial ubiquitin signal read by ZFAND6 unknown

• How a single A20/AN1 adaptor partitions among peroxisomal export, TNF/NF-κB regulation, and mitophagy, and whether these reflect one unifying ubiquitin-reading mechanism, remains unresolved.
• No structural model of A20/AN1 ubiquitin recognition
• No quantitative partitioning of ZFAND6 across its functional contexts
• Whether ZFAND6 carries intrinsic catalytic activity or only scaffolds E3s unknown